Since Zilber and Kriukoval and Svet-Moldavsky' demonstrated that some strains of Rous sarcoma virus (RSV) are capable of inducing hemorrhagic cysts or sarcomas in newborn rats, numerous attempts have been made to induce tumors by RSV in various species of mammals.3-9 One of the remarkable aspects revealed by these investigations is the strain differences in RSV for this capacity.6-9 Certain strains, such as the Schmidt-Ruppin strain, are active, while others, such as the Bryan strain, are generally inactive in mammals. The cause of such strain differences has not been elucidated.
Both BH-RSV and SR-RSV were assayed by focus formation in cultures of chick embryo cells." 8 Chick embryo cells: These were prepared from individual chick embryos derived from the eggs of Kimber Farms White Leghorn chickens, strain 813, according to the method of Rubin.18 Each embryo was classified as to two phenotypes, K and K/2, depending on whether they were, respectively, susceptible or resistant to BH-RSV(RAV-2).13 The non-virus-producing, transformed cells (NP cells) were prepared by isolating single foci of cells transformed by either BH-RSV (RAV-1) or BH-RSV(RAV-2) as described previously." ' Infection of newborn hamsters by viruses: One-tenth ml of virus suspension in tissue culture medium was injected subcutaneously into the right hip of newborn Syrian hamsters within 1 day after birth. They were palpated daily, beginning 7 days after injection, and presence or absence of tumor was finally confirmed by autopsy at 2 months after infection.
Results. Enclosure of SR-RSV in the envelope of RA V-i: Although SR-RSV can reproduce in the absence of helper virus, the yield of SR-RSV from infected cultures was significantly lower than that of BH-RSV produced from NP cells superinfected with RAV-1 or RAV-2. 16 The average titer of RSV from 1 X 106 transformed cells was about 1 X 104 FFU (focus forming units)/ml for SR-RSV and 4 X 107 FFU/ml for BH-RSV(RAV-1). However, if RAV-1 was added to the cells transformed by SR-RSV, the yield of RSV, which formed foci characteristic of SR-RSV, increased to 50-to 100-fold. Some properties of the RSV obtained from cultures to which RAV-1 was added (stock #1) are presented in Table 1 . It can be seen that this RSV was strongly interfered with by RAV-1 and neutralized significantly by antiserum to RAV-1, while the original SR-RSV was insensitive to both treatments. This indicated that the majority of RSV in this stock was SR-RSV(RAV-1). However, the results also showed that the stock still contained the parental SR-RSV in about 1 per cent. This was deduced from the relatively poor sensitivity of this stock to these two treatments compared with BH-RSV-(RAV-1). Further purification of SR-RSV(RAV-1) was achieved by treating the above stock #1 with antiserum to SR-RSV which neutralized SR-RSV exclusively. This treatment reduced the amount of SR-RSV in that stock to the level of less than 0.002 per cent of SR-RSV(RAV-1), judging from the sensitivity of the treated virus to interference by RAV-1 (Table 1) . This virus preparation was used for further studies as SR-RSV(RAV-1).
The following experiments were performed to prove the presence of intact SR-RSV genome in the SR-RSV(RAV-1). Foci were produced on K-type chick embryo cells with high dilutions of the SR-RSV(RAV-1) in the presence of antiserum to RAV-1, and ten of these foci were isolated. All ten foci produced RSV after several transfers. Examination of phenotypic properties of RSV produced from each focus showed that RSV obtained from six foci were pure SR-RSV and those from four foci were a mixture of SR-RSV and SR-RSV(RAV-1) ( Table 1) . This result can be well explained if one assumes that the cells infected with SR-RSV(RAV-1) alone produce only SR-RSV and that some foci coinfected with RAV-1 which exists in the stock of SR-RSV(RAV-1) produce both SR-RSV and SR-RSV(RAV-1).
From these results it was concluded that SR-RSV(RAV-1) consists of the genome of SR-RSV and the viral envelope which expresses the phenotypic characters of RAV-1.
Isolation of RA V-50 and preparation of BH-RSV(RA V-50): In the course of purification of SR-RSV, a helper virus stock was obtained from K-type chick embryo cells infected with dilutions of a crude preparation of SR-RSV which had once been passed in hamsters. The presence of the helper virus was recognized from the fact that the dilution beyond the end point of SR-RSV conferred on the cells either a resistance to the crude stock of SR-RSV or the cytopathic changes resembling those seen in RAV-2-infected K cells. This helper virus stock was used to activate Bryan RSV from K-type NP cells. It was found that the activated RSV stock possessed the capacity to produce sarcomas in newborn hamsters.
Since both BH-RSV(RAV-1) and BH-RSV(RAV-2) were known to be inactive in hamsters from other experiments, it was suspected that the above RSV stock might contain an unknown helper virus capable of endowing RSV with this capacity. In order to purify the putative new agent, the RSV stock was passaged twice in K/2 cells, since RAV-2 and BH-RSV(RAV-2) were found to exist in the stock as contaminants. The K/2-passaged RSV produced generally the same number of foci on K and K/2 cells'9 and was not subject to interference by RAV-1, indicating that the RSV obtained was different from all the variants of Bryan RSV hitherto isolated.13' [20] [21] [22] A pure helper virus, designated as Rous associated virus-50 or RAV-50, was isolated from this RSV stock. Finally, a stock of BH-RSV(RAV-50) was made by superinfecting NP cells with the purified RAV-50 and used for the further studies. Some properties of BH-RSV(RAV-50) are compared with those of other variants of Bryan RSV in Table 2 .
Tumor-inducing capacity of various stocks of RSV in hamsters: The capacity of Tumor induction was not observed in any hamster inoculated with high concentrations of either BH-RSV(RAV-1) or BH-RSV(RAV-2). However, prompt tumor production was accomplished by the use of BH-RSV(RAV-50). More than 80 per cent of hamsters receiving this agent developed palpable tumors, some over 1 cm in diameter, by 15 days and all 24 animals developed tumors by 20 days. Both the stock of RAV-50 and the supernatant fluid of NP cultures from which BH-RSV(RAV-50) was obtained were inactive in sarcoma formation either in chicks or in hamsters. Histological examination of two hamster tumors induced by BH-RSV(RAV-50) showed that they are typical fibrosarcomas. Trypsinized tumor cells were transplantable to all of 13 newborn hamsters. The supernatant of tumor homogenate produced no tumors in any of 7 newborn hamsters, and was not infectious to chick embryo cells, indicating that no infectious RSV was produced from the tumor cells.
In preliminary tests of the oncogenicity of BH-RSV(RAV-50) in other species of animals, it was found that 8 out of 9 newborn rats developed multiple hemorrhagic cysts and solid tumors by 15 days after injection.
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Recovery of RSV from hamster tumors: In all of the above-mentioned properties, the BH-RSV(RAV-50)-induced hamster tumors were indistinguishable from those induced by SR-RSV. However, they were different in the type of RSV genome they carried, and the two strains of RSV could be recovered from their respective hamster tumors by the following procedures. About 2 X 105 cells taken from each of four individual hamster tumors induced by BH-RSV(RAV-50) or SR-RSV, respectively, were co-cultivated in vitro with 1 X 106 chick embryo cells in the presence or absence of RAV-1, and the cultures were serially transferred at 4-day intervals. In the mixed cultures derived from SR-RSV-induced tumors, transformed chick cells appeared in all four cultures after one to two transfers, regardless of the presence or absence of RAV-1. These transformed chick cells always produced SR-RSV in the absence of RAV-1. However, in the mixed cultures derived from BH-RSV(RAV-50)-induced tumors, BH-RSV(RAV-1) was produced in all four cultures after four to five transfers only in the presence of RAV-1. Without RAV-1, neither transformed chick cells nor infectious RSV appeared in the mixed cultures. In vitro cultivation of both types of hamster tumor cells without chick embryo cells yielded no infectious RSV whether in the presence or absence of RAV-1. These results could be explained in the following way. Both SR-RSV and BH-RSV(RAV-50) are incapable of producing infectious progeny in hamster cells, but their genomes replicate at least in some proportion of hamster tumor cells. When these hamster tumor cells come in contact with chick embryo cells, the RSV genome is transferred by some mechanism from the former to the latter, as postulated by Svoboda23 for the similar finding on the RSV production following direct contact between chicken cells and rat tumor cells induced by Prague strain of RSV. As SR-RSV is nondefective, it can generate infectious RSV in the chick embryo cells without helpers, whereas the genome of defective Bryan RSV matures into infectious virus only in the presence of helper virus. In fact, the viruses recovered from the hamster tumors in this way produced foci characteristic of the respective strains used for tumor induction. These findings indicate that two types of hamster sarcoma were indeed produced by infection with BH-RSV(RAV-50) and SR-RSV, respectively.
Discussion.-The methods used here for changing the viral envelope largely depend on the inability of RSV to produce the viral envelope. The complete dependence of the Bryan RSV on helper virus for its envelope has repeatedly been demonstrated. Variants of Bryan RSV could be obtained simply by superinfecting NP cells with various helper viruses. Despite its nondefectiveness, the SchmidtRuppin RSV seems to produce a limited amount of envelope in the infected cells. Thus, the addition of RAV-1 resulted in a 50-to 100-fold increase in the yield of Schmidt-Ruppin RSV progeny, a majority of which were coated by the envelope of RAV-1 alone. Such a mixed virus could be separated from parental SR-RSV based on the difference in phenotypic characters. The results presented show that such alteration of viral envelope of RSV does not cause any stable hereditary change in its viral genome.
Contrary to the ease with which SR-RSV(RAV-1) was obtained in a relatively pure form, our original intention to enclose the Bryan RSV genome in the envelope of SR-RSV encountered a serious difficulty. It was not difficult to create such a virus by superinfecting Bryan NP cells with SR-RSV, but the product always con-tained almost equal amounts of SR-RSV itself. There were no available means to separate these two viruses, because they had the same envelope. Attempts at clonal isolation have also failed; foci initiated by the single infection with BH-RSV coated by the envelope of SR-RSV were found to be NP cells. However, a new form of Bryan RSV with tumor-inducing properties associated with a different coat was found in BH-RSV(RAV-50) when we tested the oncogenicity of various stocks of Bryan RSV. In its phenotypic properties the BH-RSV(RAV-50) differs from any one of the variants of Bryan RSV so far isolated. It rather resembles the SR-RSV in the poor virus yield and in the faster growth in K cells than in K/2 cells despite the equal plating efficiency on two types of chick embryo cells.'6 Dougherty"7 isolated an agent designated ARC (Another Rous Contaminant) from crude stock of SR-RSV. Although preliminary experiments suggest that RAV-50 differs also from the ARC, which was obtained from Dr. Dougherty, in its plating efficiency on two types of chick embryo cells, further comparison with this agent as well as virological characterization of RAV-50 is now under way.
The loss of the capacity of SR-RSV to induce hamster tumors by enclosing its genome in the RAV-1 envelope, together with the acquisition of this capacity by Bryan RSV following its coating with RAV-50 envelope, strongly supports the idea that the viral coat determines this capacity of RSV. The determining influence of viral envelope on this capacity of RSV was not entirely unexpected since the intraspecies host range of Bryan RSV has been found to depend on its viral envelope, '3, 20, 21 where the susceptibility of certain chick embryo cells to a given variant of Bryan RSV is strictly determined by the susceptibility to the helper virus used to activate RSV. Some evidence indicates that a particular RSV is unable to infect resistant chick cells because of its failure to carry out some early step of virus infection, such as adsorption, penetration, or uncoating.'3 Probably some similar barrier controls the ability or inability of RSV to infect hamster cells. Viruses like SR-RSV may have some specific macromolecules in their viral envelope which enable them to attach to or to penetrate the hamster cell membrane. Once the viral genome is incorporated into the hamster cells, RSV genome of either strain would generate malignant changes in these cells. Such specific interaction between virus envelope protein and cell membrane was first demonstrated by Holland with poliovirus.24 In a more recent study, Cords and Holland25 clearly showed that Type 1 poliovirus acquires the ability to infect ordinarily insusceptible mouse tissue by enclosing its RNA within the protein capsid of Coxsackie virus.
In contrast to failure in a number of attempts to induce mammalian tumors by the Bryan strain of RSV, which probably consists principally of BH-RSV(RAV-1), a few successes have been reported on the transformation of cultivated rat cells, 26 27 on the production of characteristic lesions in cultures of human and monkey cells,28 and on the production of tumors in hamster brains inoculated with Bryan RSV. 29 Stewart and Landon30 have reported the acquisition of mammalian tumor-inducing capacity by Bryan RSV following in vitro incubation with homogenates of various actively growing tissues, including hamster sarcoma induced by SR-RSV. Some of these results may be due to selection of oncogenic Bryan RSV variants, with a viral envelope permitting mammalian cell infection. However, there may be other factors besides viral envelope which facilitate entry of Bryan RSV genome, though they have not as yet been determined.
Summary.-Enclosure of the genome of Schmidt-Ruppin strain of RSV within the viral envelope of RAV-1 rendered it inactive in tumor induction in newborn hamsters. Among the variants of Bryan strain of RSV coated by RAV-1, RAV-2, and a newly isolated helper virus (RAV-50), only the last variant produced sarcomas in hamsters. The results are consistent with the hypothesis that the ability of RSV to induce mammalian tumors is chiefly determined by the viral envelope.
